Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.
- befree-2016 importedOn "2016-02-19" NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.
- NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_assertion wasGeneratedBy ECO_0000203 NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.
- NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_assertion wasDerivedFrom befree-2016 NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.
- NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_assertion SIO_000772 23018631 NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.
- NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_assertion evidence source_evidence_literature NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.
- NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_assertion description "[These genes belong to three major classes: genes involved in drug metabolism and transporters that influence pharmacokinetics (including the cytochrome P450 [CYP] superfamily, the organic anion transporting polypeptide [OATP] family, and the polyspecific organic cation transporter [OCT] family); genes encoding drug targets and receptors (including peroxisome proliferator-activated receptor gamma [PPARG], the adenosine triphosphate [ATP]-sensitive potassium channel [K(ATP)], and incretin receptors); and genes involved in the causal pathway of T2DM that are able to modify the effects of drugs (including adipokines, transcription factor 7-like 2 (T cell specific, HMG-box) [TCF7L2], insulin receptor substrate 1 [IRS1], nitric oxide synthase 1 (neuronal) adaptor protein [NOS1AP], and solute carrier family 30 (zinc transporter), member 8 [SLC30A8]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016128.RAje2UmbVIoxE7ZZltDnMlIIYBsdtGM_Snnf0Lw4_TSR0130_provenance.